Giant Cell Tumour Treatment in Delhi, India

A Giant Cell Tumour (GCT) is a relatively uncommon type of bone tumour characterised by the presence of multinucleated giant cells, which are large cells with multiple nuclei, along with other types of cells within the tumour mass. These tumours typically develop in the bones around the joints, such as the knee, but they can occur in any bone of the body. GCTs are generally benign, meaning they do not spread to other parts of the body (metastasize), but they can be locally aggressive, causing damage to surrounding bone tissue and potentially leading to bone fractures or other complications.

GCTs are classified as primary bone tumours, meaning they originate within the bone tissue itself rather than spreading from cancer in another part of the body. While they are most commonly found in individuals between the ages of 20 and 40, they can occur at any age, including in adolescents and older adults. Additionally, GCTs are slightly more prevalent in women compared to men.

The exact cause of Giant Cell Tumours is not fully understood. However, researchers believe that these tumours result from abnormalities in the cells responsible for bone formation (osteoblasts) and bone resorption (osteoclasts). Normally, these cells work together to maintain the balance of bone tissue in the body, with osteoblasts forming new bone and osteoclasts breaking down old bone. In Giant Cell Tumours, there is a disruption in this balance, leading to the formation of abnormal bone tissue characterised by the presence of multinucleated giant cells.

While the precise triggers for these cellular abnormalities are not known, several factors may contribute to the development of Giant Cell Tumours. These factors include genetic mutations, hormonal imbalances, and environmental influences, although further research is needed to fully understand their roles in tumour formation.

Several factors may increase an individual's risk of developing a Giant Cell Tumour. These risk factors include:

• Age: Giant Cell Tumours most commonly occur in individuals between the ages of 20 and 40. However, they can also develop in children, adolescents, and older adults.
• Gender: Giant Cell Tumours are slightly more common in women than in men, though they can affect individuals of any gender.
• Location: These tumours often occur in the long bones near joints, such as the distal femur (lower end of the thigh bone) or proximal tibia (upper end of the shin bone). However, they can also develop in other bones of the body, including the spine and pelvis.
• Bone Growth: Individuals with rapid bone growth, such as adolescents during puberty or individuals with certain bone disorders, may have a slightly higher risk of developing Giant Cell Tumours.
• Paget's Disease: People with Paget's disease of bone, a condition characterised by abnormal bone remodelling, may be at increased risk of developing Giant Cell Tumours. Paget's disease causes bones to become enlarged and weakened, creating an environment that may predispose them to tumour formation.
• Radiation Exposure: Some studies suggest that exposure to ionising radiation, such as radiation therapy for other medical conditions, may increase the risk of developing Giant Cell Tumours. However, the relationship between radiation exposure and tumour development is complex and not fully understood.

While these risk factors provide insight into who might be more susceptible to developing Giant Cell Tumours, it's important to note that not everyone with these risk factors will develop the condition. Additionally, Giant Cell Tumours can occur in individuals without any known risk factors.

Giant Cell Tumours (GCTs) can present with a variety of symptoms, although some individuals may not experience any symptoms at all, especially in the early stages of the tumour's development. When symptoms do occur, they can vary depending on the location and size of the tumour, as well as its effect on surrounding tissues. Here are some common symptoms associated with Giant Cell Tumours:

• Pain: Pain is one of the most common symptoms of Giant Cell Tumours, especially as the tumour grows and puts pressure on surrounding bone and soft tissues. The pain may be dull, achy, or sharp, and it may worsen with activity or at night.
• Swelling or Mass: A noticeable swelling or lump may develop at the site of the tumour. This swelling may be firm or tender to the touch and may increase in size over time.
• Limited Range of Motion: Giant Cell Tumours that occur near joints, such as the knee or hip, can restrict movement and cause stiffness in the affected joint. This limitation in range of motion may become more pronounced as the tumour grows.
• Weakness or Instability: As the tumour progresses, it may weaken the bone, leading to instability or a feeling of weakness in the affected limb. This can increase the risk of fractures or falls.
• Fractures: In some cases, Giant Cell Tumours can weaken the bone to the point where it becomes susceptible to fractures, even with minimal trauma or stress.
• Nerve Compression Symptoms: If the tumour compresses nearby nerves, it can cause symptoms such as numbness, tingling, or weakness in the affected area. For example, a Giant Cell Tumour in the spine may compress the spinal cord or nerve roots, leading to symptoms such as sciatica or weakness in the arms or legs.
• Difficulty Walking: Giant Cell Tumours in weight-bearing bones, such as the femur or tibia, can make walking or bearing weight on the affected limb difficult and painful.

It's important to note that these symptoms are not exclusive to Giant Cell Tumours and can occur with other conditions as well. Additionally, the severity and progression of symptoms can vary widely among individuals. If an individual experiences persistent or worsening pain, swelling, or other concerning symptoms, it's essential to consult with a healthcare professional for further evaluation and diagnosis. Early detection and treatment can help prevent complications and improve outcomes for individuals with Giant Cell Tumours.

Giant cell tumour (GCT) diagnosis typically involves a combination of medical history review, physical examination, imaging studies, and possibly a biopsy. Here's a breakdown:

• Medical History and Physical Examination: The doctor will ask about the patient’s symptoms, when they started, how they have progressed, and any relevant medical history. During the physical exam, they may assess for signs such as swelling, tenderness, and limited range of motion in the affected area.
• Imaging Studies: X-rays are often the first imaging study performed. Giant cell tumours typically appear as well-defined, eccentrically located lytic lesions within the bone, often with a thin rim of reactive bone surrounding them. Other imaging modalities such as MRI (Magnetic Resonance Imaging) or CT (Computed Tomography) scans may be used to further evaluate the tumour's extent and involvement of surrounding structures.
• Biopsy: A biopsy is usually necessary to confirm the diagnosis. This involves taking a sample of the tumour tissue, usually through a minimally invasive procedure guided by imaging techniques such as ultrasound, CT, or MRI. The sample is then examined under a microscope by a pathologist to look for the presence of characteristic features of a giant cell tumour.
• Other Tests: In some cases, additional tests may be performed to assess the extent of the tumour and its effects on surrounding tissues. This may include blood tests to assess for markers of bone metabolism or imaging studies to evaluate for any potential metastasis to other parts of the body.

Once a diagnosis of giant cell tumour is confirmed, further evaluation may be needed to determine the appropriate treatment approach, which can include options such as surgery, radiation therapy, or targeted drug therapy.

Giant cell tumours are most commonly treated with surgery to remove the tumour. The specific surgical approach depends on the size, location, and aggressiveness of the tumour. Here's a breakdown of the different surgical procedures used for giant cell tumour treatment:

• Curettage and bone grafting: This is the most common surgical procedure for giant cell tumours. During curettage, the surgeon scrapes away the tumour tissue from within the bone. A special instrument is used to remove the tumour, ensuring all of it is taken out.
• Bone grafting: After removing the tumour, the resulting cavity in the bone will be filled with bone graft. This graft material can be obtained from your own body (autograft), or from a donor (allograft), or synthetic bone substitute.
• Wide resection: In some cases, where the tumour is large or aggressive, a wider area of bone may need to be removed along with the tumour. This is called wide resection. The bone defect created by the resection will then be reconstructed using various techniques, which may involve bone grafts, plates, and screws.

Other treatment options, though less common, might be considered depending on the specific situation:

• Radiation therapy: Radiation therapy is typically not the first-line treatment for giant cell tumours due to the risk of developing new bone tumours in the radiated area. However, it may be used in specific cases, such as for tumours in locations where surgery is too risky or for tumours that recur after surgery.
• Denosumab (Xgeva): This is a medication recently approved by the FDA for the treatment of giant cell tumours. It works by targeting a protein that helps bones grow and can help shrink the tumour and improve symptoms.
• Tumour embolisation: This procedure involves blocking the arteries that supply blood to the tumour, essentially starving it of nutrients and causing it to shrink.
• Amputation: In very rare cases, if the tumour is extremely large and causes significant bone destruction, amputation of the affected limb might be necessary.

Following surgery, physical therapy is often recommended to help regain strength, mobility, and function in the affected area. Also, it's important for individuals to discuss all treatment options with their doctor to determine the best course of action for their specific situation.

Giant cell tumours, though not cancerous, can cause some complications. Here are the potential complications associated with giant cell tumours:

• Tumour recurrence: This is the most common complication of giant cell tumours.
• Osteoarthritis of the knee joint: If the tumour is located near the knee joint, it can damage the joint cartilage over time, leading to osteoarthritis and pain.
• Stress fracture: The weakened bone due to the tumour can be more susceptible to fractures.
• Limited movement: Depending on the location and size of the tumour, it can restrict movement in the nearby joint.
• Pulmonary metastasis: In very rare cases, giant cell tumours can spread (metastasize) to the lungs. This is a serious complication that requires prompt medical attention.

How common are giant cell tumours?

Giant cell tumours are relatively rare, accounting for around 5% of all primary bone tumours. They most commonly occur in individuals between the ages of 20 and 40, with a slight predominance in females. However, their exact prevalence may vary depending on factors such as geographic location and population demographics.

How can I prevent a giant cell tumour?

There are currently no known strategies for preventing the development of giant cell tumours. These tumours are not typically associated with specific preventable risk factors, and their exact cause remains unclear. However, regular monitoring and prompt treatment of any bone abnormalities or symptoms may help prevent complications associated with giant cell tumours.

Is a giant cell tumour life-threatening?

While giant cell tumours are considered benign in the sense that they do not spread to distant parts of the body like malignant tumours do, they can still cause significant complications and impairments if left untreated or if they recur. While they are not inherently life-threatening, complications such as pathological fractures or local invasion of nearby structures can have serious consequences and may require aggressive treatment.

Is GCT benign or malignant?

Giant cell tumours (GCTs) are typically classified as benign tumours. However, they can behave aggressively locally and have a tendency to recur after treatment. In rare cases, giant cell tumours may undergo malignant transformation into more aggressive forms of cancer known as malignant giant cell tumours or giant cell sarcomas. These malignant transformations are uncommon but may present additional challenges in terms of treatment and prognosis.

Who treats giant cell tumours?

Giant cell tumours are typically managed by a multidisciplinary team of healthcare professionals, including orthopaedic surgeons, medical oncologists, radiation oncologists, and pathologists. The specific treatment approach depends on factors such as the tumour's size, location, and aggressiveness, as well as the patient's overall health and preferences. Orthopaedic surgeons often lead the surgical management of giant cell tumours, while medical oncologists may be involved in cases requiring adjuvant therapy such as targeted drug treatment or radiation therapy.

What is the outlook/prognosis for giant cell tumours?

The outlook for giant cell tumours (GCTs) varies depending on factors such as tumour size, location, and treatment response. While many GCTs can be successfully treated, they have a relatively high recurrence rate, and long-term follow-up is often necessary to monitor for any signs of recurrence or progression.

How often should I follow up with my healthcare provider after treatment for a giant cell tumour?

It's important to follow your healthcare provider's recommendations for follow-up care, which typically involves regular check-ups and imaging studies to monitor for any signs of recurrence or complications. The frequency of follow-up visits may vary depending on individual factors and the specifics of your treatment plan.

Can physical activity or exercise exacerbate symptoms of a giant cell tumour?

In general, low-impact exercise and physical activity are encouraged for individuals with giant cell tumours, as they can help maintain joint mobility, muscle strength, and overall well-being. However, it's essential to consult with your healthcare provider or a physical therapist to determine appropriate activities and any necessary modifications based on your specific situation.

Are there any specific precautions I should take to protect against fractures if I have a giant cell tumour?

Depending on the location and size of the tumour, as well as its effect on bone integrity, your healthcare provider may recommend certain precautions to reduce the risk of fractures. This may include avoiding high-impact activities, using assistive devices such as crutches or braces, and taking steps to minimise falls or trauma to the affected area.

Can giant cell tumours affect fertility or pregnancy?

While giant cell tumours typically do not directly affect fertility or pregnancy, certain treatment modalities, such as radiation therapy or certain medications, may have implications for reproductive health. If you are of childbearing age and have been diagnosed with a giant cell tumour, it's important to discuss any potential concerns or considerations with your healthcare provider.

Is there a risk of developing osteoarthritis or other joint-related conditions following treatment for a giant cell tumour near a joint?

In some cases, individuals who have undergone treatment for giant cell tumours near joints may experience long-term joint stiffness, reduced range of motion, or other joint-related symptoms. Physical therapy and rehabilitation following treatment can help minimise these effects, and in some cases, joint-preserving surgical techniques may be employed to maintain joint function. However, the extent of joint involvement and potential long-term effects can vary depending on individual factors and the specifics of the treatment received.

What is recovery like after surgery?

Recovery time varies depending on the type of surgery performed. Typically, after curettage and bone grafting, recovery can take several weeks to months. You might experience some pain and swelling initially, but physical therapy can help you regain strength and mobility in the affected area. For wider resection procedures, recovery might take longer and may involve more intensive rehabilitation.

What are the Giant Cell Tumour recurrence signs that I should watch out for?

While recurrence is a possibility, following your doctor's recommendations for follow-up care is crucial. This will likely involve regular imaging tests to monitor the treated area. Early detection of any recurrence allows for prompt intervention and can improve treatment outcomes. Be aware of any new pain, swelling, or limitations in movement around the previously affected bone or joint, and report these symptoms to your doctor right away.

Reviewed by Dr. Gopal Sharma, Vice Chairman - Medical Oncology (Breast, Thoracic, Gynaecology), on 09 December 2025.